AREV Life Sciences Global Revenue

AREV Life Sciences Global had revenue of 7.21K CAD in the twelve months ending September 30, 2023, down -96.08% year-over-year. In the year 2022, AREV Life Sciences Global had annual revenue of 49.11K, down -80.74%.

Revenue (ttm)

7.21K CAD

Revenue Growth

-96.08%

P/S Ratio

2.98

Revenue / Employee

3.60K CAD

Employees

Market Cap

15.88K USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	49.11K	-205.88K	-80.74%
Dec 31, 2021	255.00K	64.42K	33.80%
Dec 31, 2020	190.58K	-4.11K	-2.11%
Dec 31, 2019	194.69K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro
Dec 31, 2013	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Veritas Farms	883.65K
Wuhan General Group (China)	80.38M
Aeolus Pharmaceuticals	771.00K
Body and Mind	22.98M
CaliPharms	112.47K
Acura Pharmaceuticals	1.56M
Redwood Scientific Technologies	259.71K
EVIO, Inc.	2.36M

Revenue Rankings

AREV Life Sciences Global News

4 years ago - Kevin Phelps, CPA Appointed Chief Operating Officer of Arev Life Sciences Global Corporation & Warrant Offering - GlobeNewsWire
4 years ago - AREV Life Sciences Global Corporation announces engagement of TransBIOTech to facilitate preclinical therapeutic pipeline development - GlobeNewsWire
4 years ago - AREV Life Sciences Completes Lab and Fungi Fruiting Room Build - GlobeNewsWire
5 years ago - AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB - GlobeNewsWire
5 years ago - AREV Announces Brian Cameron as Chief Financial Officer - GlobeNewsWire
5 years ago - Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN™, a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation - GlobeNewsWire
5 years ago - AREV Annual and Special General Meeting Results - GlobeNewsWire
5 years ago - AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc. - GlobeNewsWire

More News